Zealand Pharma (ZLDPF) announces the appointment of Utpal Singh as Chief Scientific Officer. Utpal will join the executive team to lead discovery research and translational sciences at Zealand Pharma. Most recently, he served as Senior Vice President of Small Molecule Discovery at Eli Lilly and Company (LLY).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma launches long-term incentive programs for board of directors
- Zealand Pharma upgraded to Overweight from Equal Weight at Morgan Stanley
- Zealand Pharma completes enrollment in ZUPREME-1 trial
- Zealand Pharma upgraded to Buy from Hold at SEB Equities
- Zealand Pharma to pay $350M to Roche in petrelintide collaboration, license pact